R
Robert C. Rostomily
Researcher at Houston Methodist Hospital
Publications - 102
Citations - 5227
Robert C. Rostomily is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Glioma & Radiation therapy. The author has an hindex of 34, co-authored 98 publications receiving 4486 citations. Previous affiliations of Robert C. Rostomily include Henry Ford Hospital & Cornell University.
Papers
More filters
Journal ArticleDOI
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill,Jacob O. Kitzman,Sabine Hellwig,Noah C. Welker,Riza M. Daza,Daniel N. Baker,Keith M. Gligorich,Robert C. Rostomily,Mary P. Bronner,Jay Shendure +9 more
TL;DR: Findings provide compelling evidence that experimental or bioinformatic isolation of a specific subset of fragment lengths from cell-free DNA may improve detection of ctDNA.
Journal ArticleDOI
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu,Zhan Zhang,Wenyu Zhou,Amy Wang,John M. Heddleston,Claudia M A Pinna,Alexis Hubaud,Bradford M. Stadler,Michael Choi,Merav Bar,Muneesh Tewari,Alvin Y. Liu,Robert L. Vessella,Robert C. Rostomily,Donald E. Born,Marshall S. Horwitz,Carol B. Ware,C. Anthony Blau,Michele A. Cleary,Jeremy N. Rich,Hannele Ruohola-Baker +20 more
TL;DR: Hypoxia, through hypoxia-inducible factor (HIF), can induce an hESC-like transcriptional program, including the induced pluripotent stem cell (iPSC) inducers, OCT4, NANOG, SOX2, KLF4, cMYC, and microRNA-302 in 11 cancer cell lines.
Journal ArticleDOI
An anatomic transcriptional atlas of human glioblastoma
Ralph B. Puchalski,Nameeta Shah,Jeremy A. Miller,Rachel A. Dalley,Steve R. Nomura,Jae Guen Yoon,Kimberly A. Smith,Michael Lankerovich,Darren Bertagnolli,Kris Bickley,Andrew F. Boe,Krissy Brouner,Stephanie Butler,Shiella Caldejon,Mike Chapin,Suvro Datta,Nick Dee,Tsega Desta,Tim A. Dolbeare,Nadezhda Dotson,Amanda Ebbert,David Feng,Xu Feng,Michael S. Fisher,Garrett Gee,Jeff Goldy,Lindsey Gourley,Benjamin W. Gregor,Guangyu Gu,Nika Hejazinia,John G. Hohmann,Parvinder Hothi,Robert Howard,Kevin M. Joines,Ali Kriedberg,Leonard Kuan,Chris Lau,Felix Lee,Hwahyung Lee,Tracy Lemon,Fuhui Long,Naveed Mastan,Erika Mott,Chantal Murthy,Kiet Ngo,Eric Olson,Melissa Reding,Zack Riley,David Rosen,David Sandman,Nadiya V. Shapovalova,Clifford R. Slaughterbeck,Andrew Sodt,Graham Stockdale,Aaron Szafer,Wayne Wakeman,Paul Wohnoutka,Steven J. White,Don Marsh,Robert C. Rostomily,Robert C. Rostomily,Lydia Ng,Chinh Dang,Allan R. Jones,Bart Keogh,Haley Gittleman,Jill S. Barnholtz-Sloan,Patrick J. Cimino,Megha S Uppin,C. Dirk Keene,Farrokh Farrokhi,Justin D. Lathia,Michael E. Berens,Antonio Iavarone,Amy Bernard,Ed S. Lein,John W. Phillips,Steven Rostad,Charles Cobbs,Michael Hawrylycz,Greg Foltz +80 more
TL;DR: The Ivy Glioblastoma Atlas is presented, an anatomically based transcriptional atlas of human gliOBlastoma that aligns individual histologic features with genomic alterations and gene expression patterns, thus assigning molecular information to the most important morphologic hallmarks of the tumor.
Journal ArticleDOI
A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle
TL;DR: The concordance between predicted and actual survivals suggests that the mathematical model is realistic enough to allow precise definition of the effectiveness of individualised treatments and their site(s) of action on proliferation (ρ) and/or dispersal (D) of the tumour cells without knowledge of any other clinical or pathological information.
Journal ArticleDOI
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Svetlana A. Mikheeva,Andrei M. Mikheev,Audrey Petit,Richard P. Beyer,Robert G. Oxford,Leila Khorasani,John Patrick Maxwell,Carlotta A. Glackin,Hiroaki Wakimoto,Inés González-Herrero,Isidro Sánchez-García,John R. Silber,Philip J. Horner,Robert C. Rostomily +13 more
TL;DR: It is demonstrated that TWIST1 enhances GBM invasion in concert with mesenchymal change not involving the canonical cadherin switch of carcinoma EMT, which support the potential therapeutic importance of strategies to subvert TWist1-mediated mesenchyal change.